Article citationsMore>>

Post, M.S., Christella, M., Thomassen, L.G., van der Mooren, M.J., van Baal, W.M., Rosing, J., et al. (2003) Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: A randomized, placebo-controlled study in post-menopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1116-1121. doi:10.1161/01.ATV.0000074146.36646.C8

has been cited by the following article:

• TITLE: The effects of obesity on venous thromboembolism: A review

  AUTHORS: Genyan Yang, Christine De Staercke, W. Craig Hooper

  KEYWORDS: Obesity; Comorbidity; Deep Vein Thrombosis; Pulmonary Embolism; Venous Thromboembolism; Risk Factor; Prevention

  JOURNAL NAME: Open Journal of Preventive Medicine, Vol.2 No.4, November 29, 2012

  ABSTRACT: Obesity has emerged as a global health issue that is associated with wide spectrum of disorders, including coronary artery disease, diabetes mellitus, hypertension, stroke, and venous thromboembolism (VTE). VTE is one of the most common vascular disorders in the United States and Europe and is associated with significant mortality. Although the association between obesity and VTE appears to be moderate, obesity can interact with other environmental or genetic factors and pose a significantly greater risk of VTE among individuals who are obese and who are exposed simultaneously to several other risk factors for VTE. Therefore, identification of potential interactions between obesity and certain VTE risk factors might offer some critical points for VTE interventions and thus minimize VTE morbidity and mortality among patients who are obese. However, current obesity measurements have limitations and can introduce contradictory results in the outcome of obesity. To overcome these limitations, this review proposes several future directions and suggests some avenues for prevention of VTE associated with obesity as well.